Moreover, as noted in non-transplanted patients with CKD, higher FGF23 levels might be more consistently associated with cardiovascular volume overload complications (i.e., LVH and congestive heart failure) [82,110] than with ischemic heart disease or atherosclerosis [111,112]. The gene discussed is FGF23; the disease is coronary artery disorder.